DCRT at workshop of the DARTER COST Action
No less than three DCRT coordinators actively contributed to the workshop of the Delivery of Antisense RNA Therapy (DARTER) COST Action that took place from July 19-21. DARTER is a network that aims to foster and facilitate antisense oligonucleotide research in Europe by achieving consensus on which model systems to use to improve delivery and study safety and toxicity of oligonucleotide therapies. COST Actions are funded by the cooperation of science and technology (COST. These networks are open to new participants also after the network has initiated. For more information on DARTER look on the antisenserna website.
During the workshop Willeke van Roon-Mom presented on delivery to brain and cell and animal model systems to test this. Rob Collin presented on delivery to the eye and the development of antisense oligonucleotide therapies for genetic retinal diseases. Finally, Annemieke Aartsma-Rus presented in the “negative results” session. DARTER and DCRT strongly believe that it is important to publish also about hypotheses and ideas that turned out not to work. Sharing these findings will avoid unnecessary duplication of work. Furthermore, hypotheses that are disproven also advance science.
published on Jul 29, 2021
Bachelor student Noortje Groenendijk joins DCRT for an internship
Keynotes, invited speakers and sponsors at DATS 2025 in Groningen
Master student Tracy Wüsthoff joins the DCRT for an internship
Come and join the DCRT at the Dutch Antisense Therapeutics Symposium in Groningen!
Master student Okke Faber joins the DCRT
DCRT's Ype Elgersma will be interviewed on television about his work on epilepsy
Happy Christmas holidays from all of us at DCRT!
Guest researchers at the DCRT
Join us on 12 and 13 June 2025 in Groningen, The Netherlands, for the 4th Dutch Antisense Therapeutics Symposium
DCRT interview in the newsletter of Centre for Future Affordable Sustainable Therapy Development (FAST)